Evidence map›Paper›PMID 29313411›Full record

ArticleAutophagy2018

Inhibition of WNT-CTNNB1 signaling upregulates SQSTM1 and sensitizes glioblastoma cells to autophagy blockers.

Mireia Nàger, Marta C Sallán, Anna Visa, Charumathi Pushparaj, Maria Santacana, Anna Macià, Andrée Yeramian, Carles Cantí, Judit Herreros

Open access · bronzeAbstract read
In one paragraph

Article in Autophagy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 101 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Radioresistance Mechanisms in Head and Neck Cancer.Clinical and experimental otorhinolaryngology · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mireia Nàgera Department of Basic Medical Sciences , University of Lleida, IRBLleida , Lleida , Spain.ORCID 0000-0002-0352-557X
Marta C Sallánb Department of Experimental Medicine , University of Lleida, IRBLleida , Lleida , Spain.
Anna Visab Department of Experimental Medicine , University of Lleida, IRBLleida , Lleida , Spain.
Charumathi Pushparajb Department of Experimental Medicine , University of Lleida, IRBLleida , Lleida , Spain.
Maria Santacanac Immunohistochemistry Unit , IRBLleida , Lleida , Spain.
Anna Maciàb Department of Experimental Medicine , University of Lleida, IRBLleida , Lleida , Spain.
Andrée Yeramiana Department of Basic Medical Sciences , University of Lleida, IRBLleida , Lleida , Spain.
Carles Cantíb Department of Experimental Medicine , University of Lleida, IRBLleida , Lleida , Spain.ORCID 0000-0003-3854-9712
Judit Herrerosa Department of Basic Medical Sciences , University of Lleida, IRBLleida , Lleida , Spain.ORCID 0000-0003-4200-0853
Universitat de Lleida · ESInstituto de Investigación Biomédica de Lleida · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

WNT-CTNN1B signaling promotes cancer cell proliferation and stemness. Furthermore, recent evidence indicates that macroautophagy/autophagy regulates WNT signaling. Here we investigated the impact of inhibiting WNT signaling on autophagy in glioblastoma (GBM), a devastating brain tumor. Inhibiting TCF, or silencing TCF4 or CTNNB1/β-catenin upregulated SQSTM1/p62 in GBM at transcriptional and protein levels and, in turn, autophagy. DKK1/Dickkopf1, a canonical WNT receptor antagonist, also induced autophagic flux. Importantly, TCF inhibition regulated autophagy through MTOR inhibition and dephosphorylation, and nuclear translocation of TFEB, a master regulator of lysosomal biogenesis and autophagy. TCF inhibition or silencing additionally affected GBM cell proliferation and migration. Autophagy induction followed by its blockade can promote cancer cell death. In agreement with this notion, halting both TCF-CTNNB1 and autophagy pathways decreased cell viability and induced apoptosis of GBM cells through a SQSTM1-dependent mechanism involving CASP8 (caspase 8). In vivo experiments further underline the therapeutic potential of such dual targeting in GBM.

Indexed as

Autophagybeta CateninCell Line, TumorGlioblastomaHumansLysosomesRNA, Small InterferingSequestosome-1 ProteinSignal TransductionTranscription Factor 4beta CateninCTNNB1 protein, humanRNA, Small InterferingSequestosome-1 ProteinSQSTM1 protein, humanTCF4 protein, humanTranscription Factor 4AutophagyCTNNB1glioblastomaSQSTM1TCFTFEBWNT

Identifiers

PMID29313411
PMCPMC5959333
OpenAlexW2784008665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.